Healthmed Services : Financial statement

HEALTHMED SERVICES, LTD.

Balance Sheets

(Unaudited)

ASSETS		June 30, 2022		December 31, 2021
Current assets
Cash		-			-
Total current assets		-			-
Total assets
$	-	$	-
LIABILITIES AND STOCKHOLDERS' DEFICIT
Current liabilities
Accounts payable and accrued liabilities		6,661			2,952
Due to related party		44,943			32,694
Total current liabilities		51,604			35,646
Total liabilities		51,604			35,646
Stockholders' deficit
Preferred stock, par value $.001; 75,000,000 shares authorized;
50,000,000 and 50,000,000 issued and outstanding as of
June 30, 2022 and December 31, 2021, respectively.		50,000			50,000
Common stock; $0.0001 par value; ,1,000,000,000 shares authorized;
532,313,003 and 627,313,003 shares issued and outstanding as of
June 30, 2022 and December 31, 2021, respectively.		532,313			627,313
Additional paid-in capital		182,750			87,750
Accumulated deficit		(816,667)			(800,709)
Total stockholders' deficit		(51,604)			(35,646)
Total liabilities and stockholders' deficit
$	-	$	-

The accompanying notes are an integral part of these audited financial statements

No assurance provided

HEALTHMED SERVICES, LTD. STATEMENTS OF OPERATIONS (Unaudited)

		For the three months ended			For the six months ended
		June 30, 2022			June 30, 2021			June 30, 2022			June 30, 2021
Revenue		-			-			-			-
Operating expenses
General and administrative		13,708			9,440			15,958			9,440
Total operating expenses		13,708			9,440			15,958			9,440
Loss from operations		(13,708)			(9,440)			(15,958)			(9,440)
Net Income	$	(13,708)		$	(9,440)		$	(15,958)		$	(9,440)
Net loss per common share: basic and diluted	$	(0.00)	$	(0.00)	$	(0.00)	$	(0.00)
Basic weighted average common
shares outstanding		595,994,322			627,153,003			611,567,147			627,153,003

The accompanying notes are an integral part of these audited financial statements

No assurance provided

HEALTHMED SERVICES, LTD.

CONSOLIDATED STATEMENTS OF STOCKHOLDERS' DEFICIT

(Unaudited)

	Preferred Stock	Common Stock			Additional		Accumulated			Total Stockholders'
	Shares			Amount	Shares			Amount		Paid-in Capital		Deficit			Deficit
Balance, December 31, 2021	50,000,000		50,000	627,313,003			627,313		87,750		(800,709)		(35,646)
Net loss
-		-	-			-		-		(2,250)		(2,250)
Balance, March 31, 2022	50,000,000	50,000	627,313,003			627,313	87,750	(802,959)	(37,896)
Return and cancellation of common stock	-			-	(95,000,000)			(95,000)		95,000		-			-
Net loss	-		-	-			-		-		(13,708)		(13,708)
Balance, June 30, 2022	50,000,000			50,000	532,313,003			532,313		182,750		(816,667)			(51,604)
Balance, December 31, 2020
50,000,000	50,000	627,153,003			627,153	-	(677,313)	-
Net loss
-	-	-			-	-	-	-
Balance, March 31, 2021	50,000,000		50,000	627,153,003			627,153		-		(677,313)		-
Return and cancellation of preferred stock
(45,000,000)	(45,000)	-			-	-	45,000.00	-
Net loss	-	-	-			-	-	(9,440)	(9,440.00)
Balance, June 30, 2021	5,000,000		5,000	627,153,003			627,153		-		(641,753)		(9,440)

The accompanying notes are an integral part of these audited financial statements

No assurance provided

-

-

-

-

-

HEALTHMED SERVICES, LTD. STATEMENTS OF CASH FLOWS (Unaudited)

		For six months ended
		June 30, 2022			June 30, 2022
Cash Flows from Operating Activities	$	(15,958)	$	(9,400)
Net Income
Adjustments to reconcile net loss to net cash provided by operating activities:
Changes in assets and liabilities
Accounts payable		3,709			-
Net cash used in operating activities		(12,249)			(9,400)
Cash Flows from Financing Activities
Proceeds from related party debt		12,249			9,400
Net cash from financing activities		12,249			9,400
Net increase (decrease) in cash		-			-
Cash, beginning of period		-			-
Cash, end of period	$	-	$	-
Supplemental disclosure of cash flow information
Cash paid for interest	$	-	$	-
Cash paid for taxes
$	-	$	-
Non-Cash investing and financing transactions
Return and cancellation of preferred shares	$	-		$	45,000
Return and cancellation of common stock
$	95,000	$	-

The accompanying notes are an integral part of these audited financial statements

No assurance provided

HEALTHMED SERVICES, LTD.

NOTES TO FINANCIAL STATEMENTS

JUNE 30, 2022 (Unaudited)

NOTE 1 - NATURE AND DESCRIPTION OF BUSINESS

HealthMed Services, Ltd. the ("the Company") was incorporated in the State of Nevada on September 14, 2000 as Telemax Communications, Inc. On July 14, 2003, the Company changed its name to HealthMed Services, Ltd. TheCompany has no operations and in accordance with Accounting Standards Codification (ASC) Topic 915 is considered to be in the development stage.

On April 16, 2021, A board member agreed to sell, assign, and transfer 4,850,000 shares of Company's Series A Preferred Stock and deliver to the Company for cancellation and return to treasury 45,000,000 shares of Company Series A Preferred Stock.

On April 27, 2021, James Shipley resigned as President, Secretary, Treasurer, and Director of the Company at which time Rasmus Refer was appointed to these positions.

NOTE 2 - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES

Basis of presentation

The Company's financial statements have been prepared in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP").

The financial statements have been prepared in accordance with accounting principles generally accepted in The United States of America and the rules and regulations of the OTC Markets alternative reporting standard for interim financial information. Accordingly, they do not include all the information necessary for a comprehensive presentation of financial position and results of operations.

It is management's opinion, however, that all material adjustments (consisting of normal and recurring adjustments)have been made which are necessary for a fair financial statements presentation. The results for the interim period are not necessarily indicative of the results to be expected for the year.

Use of estimates

The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of revenue and expenses during the reporting period. Actual results could differ significantly from those estimates.

Cash and cash equivalents

For the purpose of the statements of cash flows, all highly liquid investments with an original maturity of three months or less are considered to be cash equivalents. The carrying value of these investments approximates fair value. The Company did not have any cash equivalents as of June 30, 2022 and December 31, 2021.

Stock-based compensation

The Company follows ASC 718-10, "Stock Compensation", which addresses the accounting for transactions in which an entity exchanges its equity instruments for goods or services, with a primary focus on transactions in which an entity obtains employee services in share-based payment transactions. ASC 718-10 is a revision to SFAS No. 123, "Accounting for Stock-Based Compensation," and supersedes Accounting Principles Board ("APB") Opinion No. 25, "Accounting for Stock Issued to Employees," and its related implementation guidance. ASC 718-10 requires measurement of the cost of employee services received in exchange for an award of equity instruments based on the grant-date fair value of the award (with limited exceptions). Incremental compensation costs arising from subsequent modifications of awards after the grant date must be recognized.

Earnings per share

The Company follows ASC Topic 260 to account for the earnings per share. Basic earnings per common share ("EPS") calculations are determined by dividing net income by the weighted average number of shares of common stock outstanding during the year. Diluted earnings per common share calculations are determined by dividing net income by the weighted average number of common shares and dilutive common share equivalents outstanding. During periods when common stock equivalents, if any, are anti-dilutive they are not considered in the computation.

The accompanying notes are an integral part of these unaudited financial statements

No assurance provided